What Is Genomic High-Risk Myeloma?
Although treatment of multiple myeloma has changed dramatically over time, there is still a subpopulation of patients who do not respond to treatments and are labeled as high risk. A combination of serum and genomic markers can be used to identify and stratify these patients according to association...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2022-04-01
|
| Seri Bilgileri: | Hemato |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/2673-6357/3/2/21 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|